Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetically Heterogeneous and Clonally Unrelated Metastases May Arise in Patients With Cutaneous Melanoma
Terrence M. Katona, Timothy D. Jones, Ming‐Sheng Wang, et al.
The American Journal of Surgical Pathology (2007) Vol. 31, Iss. 7, pp. 1029-1037
Closed Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Parallel progression of primary tumours and metastases
Christoph A. Klein
Nature reviews. Cancer (2009) Vol. 9, Iss. 4, pp. 302-312
Closed Access | Times Cited: 1085
Spatially Resolved Transcriptomics Enables Dissection of Genetic Heterogeneity in Stage III Cutaneous Malignant Melanoma
Kim Thrane, Hanna Eriksson, Jonas Maaskola, et al.
Cancer Research (2018) Vol. 78, Iss. 20, pp. 5970-5979
Open Access | Times Cited: 315
Intra- and Inter-Tumor Heterogeneity of BRAFV600EMutations in Primary and Metastatic Melanoma
Molly Yancovitz, Adam J. Litterman, Joanne Yoon, et al.
PLoS ONE (2012) Vol. 7, Iss. 1, pp. e29336-e29336
Open Access | Times Cited: 286
Intratumor and Intertumor Heterogeneity in Melanoma
Tomasz M. Grzywa, Wiktor Paskal, Paweł Włodarski
Translational Oncology (2017) Vol. 10, Iss. 6, pp. 956-975
Open Access | Times Cited: 260
Cell-to-cell fusion as a link between viruses and cancer
Dominik M. Duelli, Yuri Lazebnik
Nature reviews. Cancer (2007) Vol. 7, Iss. 12, pp. 968-976
Closed Access | Times Cited: 200
Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis
Nikolas H. Stoecklein, Christoph A. Klein
International Journal of Cancer (2009) Vol. 126, Iss. 3, pp. 589-598
Open Access | Times Cited: 184
Normal stem cells and cancer stem cells: similar and different
Mark Shackleton
Seminars in Cancer Biology (2010) Vol. 20, Iss. 2, pp. 85-92
Closed Access | Times Cited: 158
Systemic treatment for BRAF-mutant melanoma: where do we go next?
Alexander M. Menzies, Georgina V. Long
The Lancet Oncology (2014) Vol. 15, Iss. 9, pp. e371-e381
Closed Access | Times Cited: 135
Using tumour phylogenetics to identify the roots of metastasis in humans
Kamila Naxerova, Rakesh K. Jain
Nature Reviews Clinical Oncology (2015) Vol. 12, Iss. 5, pp. 258-272
Closed Access | Times Cited: 134
Biopsies: next-generation biospecimens for tailoring therapy
Mark Basik, Adriana Aguilar‐Mahecha, Caroline Rousseau, et al.
Nature Reviews Clinical Oncology (2013) Vol. 10, Iss. 8, pp. 437-450
Closed Access | Times Cited: 118
Mapping cancer biology in space: applications and perspectives on spatial omics for oncology
Sumin Lee, Gyeongjun Kim, JinYoung Lee, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Inter- and Intra-Patient Heterogeneity of Response and Progression to Targeted Therapy in Metastatic Melanoma
Alexander M. Menzies, Lauren E. Haydu, Matteo S. Carlino, et al.
PLoS ONE (2014) Vol. 9, Iss. 1, pp. e85004-e85004
Open Access | Times Cited: 87
Cancer Stem Cells in Tumor Heterogeneity
Alexander Pietras
Advances in cancer research (2011), pp. 255-281
Open Access | Times Cited: 80
Molecular and genetic diversity in the metastatic process of melanoma
Katja Harbst, Martin Lauss, Helena Cirenajwis, et al.
The Journal of Pathology (2014) Vol. 233, Iss. 1, pp. 39-50
Open Access | Times Cited: 67
Intratumoral Heterogeneity in a Trp53-Null Mouse Model of Human Breast Cancer
Mei Zhang, Anna Tsimelzon, Chi-Hsuan Chang, et al.
Cancer Discovery (2015) Vol. 5, Iss. 5, pp. 520-533
Open Access | Times Cited: 67
Chromosome 3 Intratumor Heterogeneity in Uveal Melanoma
Hanneke W. Mensink, Jolanda Vaarwater, Emine Kılıç, et al.
Investigative Ophthalmology & Visual Science (2009) Vol. 50, Iss. 2, pp. 500-500
Closed Access | Times Cited: 77
Laser-assisted Microdissection in Translational Research
Liang Cheng, Shaobo Zhang, Gregory T. MacLennan, et al.
Applied immunohistochemistry & molecular morphology (2012) Vol. 21, Iss. 1, pp. 31-47
Closed Access | Times Cited: 66
Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma
Emilia Hugdahl, May Britt Kalvenes, Monica Mannelqvist, et al.
British Journal of Cancer (2017) Vol. 118, Iss. 1, pp. 98-105
Open Access | Times Cited: 57
Multiclonal tumor origin: Evidence and implications
Barbara L. Parsons
Mutation Research/Reviews in Mutation Research (2018) Vol. 777, pp. 1-18
Open Access | Times Cited: 57
Pancreatic Cancer Metastasis: Are we being Pre-EMTed?
Srustidhar Das, Surinder K. Batra
Current Pharmaceutical Design (2015) Vol. 21, Iss. 10, pp. 1249-1255
Open Access | Times Cited: 55
Molecular pathology of malignant melanoma: changing the clinical practice paradigm toward a personalized approach
Joshua R. Bradish, Liang Cheng
Human Pathology (2014) Vol. 45, Iss. 7, pp. 1315-1326
Closed Access | Times Cited: 50
18F-labelled fluorodeoxyglucose–positron emission tomography (FDG–PET) heterogeneity of response is prognostic in dabrafenib treated BRAF mutant metastatic melanoma
Matteo S. Carlino, Catherine A.B. Saunders, Lauren E. Haydu, et al.
European Journal of Cancer (2012) Vol. 49, Iss. 2, pp. 395-402
Closed Access | Times Cited: 49
High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer
Marion Jeantet, David Tougeron, Gaëlle Tachon, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 12, pp. 2015-2015
Open Access | Times Cited: 43
Laser capture microdissection in the genomic and proteomic era: targeting the genetic basis of cancer.
Barbara Domazet, Gregory T. MacLennan, Antonio López-Beltrán, et al.
PubMed (2008)
Closed Access | Times Cited: 56
Discordancy in BRAF mutations among primary and metastatic melanoma lesions: clinical implications for targeted therapy
Joshua R. Bradish, Justin D. Richey, Kristin Post, et al.
Modern Pathology (2014) Vol. 28, Iss. 4, pp. 480-486
Closed Access | Times Cited: 41
Page 1 - Next Page

Scroll to top